Creatine Is the Most Studied Ergogenic Supplement in History — but the Most Overlooked Finding Is That It Also Improves Cognition in Humans by +23% on Working Memory and +15% on Fluid Intelligence Tests, Brain Phosphocreatine Stores Decline With Aging at the Same Rate as Muscle Creatine, and 3–5g/Day of Creatine Monohydrate Is One of the Best-Supported, Lowest-Risk, Most Versatile Longevity Supplements Available
Updated: June 2026 · creatine · creatine supplement · creatine benefits · creatine monohydrate · creatine for longevity · creatine aging · creatine brain · creatine cognition · creatine memory · creatine intelligence · creatine mental performance · creatine for elderly · creatine for seniors · creatine and aging muscle · creatine sarcopenia · creatine and bone · creatine phosphocreatine · phosphocreatine system · ATP phosphocreatine · creatine kinase · PCr ATP replenishment · creatine brain energy · Rae 2003 · Rae creatine cognition · creatine Proceedings Royal Society · creatine working memory · creatine backward digit span · creatine Raven progressive matrices · creatine IQ · creatine and IQ · creatine cognitive test · creatine vegetarian · vegetarian creatine response · creatine vegetarian advantage · creatine baseline · creatine dose-response vegetarian · creatine monohydrate vs HCl · creatine HCl · buffered creatine · Kre-Alkalyn · creatine ethyl ester · creatine forms · best creatine form · creatine monohydrate evidence · creatine monohydrate gold standard · creatine monohydrate vs other forms · creatine loading · creatine loading phase · creatine no loading phase · creatine 3g daily · creatine 5g daily · how much creatine to take · creatine timing · when to take creatine · creatine with carbs · creatine insulin · creatine water weight · creatine water retention · creatine and bloating · creatine kidney safety · creatine kidney disease · creatine creatinine · creatine and hair loss · creatine DHT · creatine hair loss study · van der Merwe 2009 · creatine DHT rugby · creatine neurological · creatine depression · creatine antidepressant · creatine bipolar · creatine TBI · creatine concussion · creatine MELAS · creatine mitochondrial disease · SLC6A8 creatine transporter · creatine deficiency · creatine synthesis · arginine glycine amidinotransferase · AGAT · guanidinoacetate methyltransferase · GAMT · creatine biosynthesis · meat and creatine · creatine from food · creatine red meat · creatine fish
Creatine (α-methylguanidinoacetic acid) is a nitrogenous compound synthesized endogenously from arginine and glycine in the kidney and liver (via arginine:glycine amidinotransferase, AGAT) and then methylated from methionine (via guanidinoacetate methyltransferase, GAMT) to form creatine. It is also obtained from diet, primarily from red meat and fish (~1–2g creatine per 500g of raw meat/fish). The total body creatine pool in a 70kg adult is approximately 120–140g, with ~95% stored in skeletal muscle (60% as phosphocreatine, 40% as free creatine). The remaining ~5% is distributed in the brain, heart, testes, and other high-energy-demand tissues.
The physiological role of creatine is as a high-speed, high-capacity energy buffer: the phosphocreatine (PCr)/creatine kinase (CK) system rapidly regenerates ATP from ADP during the first 5–10 seconds of maximal energy demand, before oxidative phosphorylation or glycolysis can ramp up. This makes PCr particularly important in: skeletal muscle during explosive/high-intensity exercise (the first 5–10 seconds of an all-out sprint are fueled ~70% by PCr); cardiac muscle (heart creatine kinase is constitutively active — PCr provides immediate ATP during increased cardiac work); brain neurons (the brain consumes ~20% of total body ATP at rest despite being 2% of body mass; neuronal PCr stores buffer ATP during sustained cognitive load; synaptic transmission requires continuous ATP for vesicle cycling, ion pump maintenance, and cytoskeletal dynamics). With aging, creatine stores decline in both muscle and brain — which is now understood to contribute to both sarcopenia and age-related cognitive decline.
+23% Working Memory
Rae CS et al. (2003, Proceedings of the Royal Society B: Biological Sciences): the landmark creatine cognition trial; DESIGN: double-blind, randomized crossover trial; N=45 young adult vegetarians (median age 23); INTERVENTION: creatine monohydrate 5g/day × 6 weeks vs placebo; washout: 6 weeks; then crossover; RATIONALE FOR VEGETARIANS: vegetarians have negligible dietary creatine intake (no meat or fish) → lower baseline muscle and brain creatine stores → larger supplementation effect; meat-eaters have partially saturated creatine stores (dietary creatine in muscle is ~60–70% of the maximum supplementation can achieve); vegetarians start from ~20–40% lower baseline → larger % increase from supplementation → larger functional effect; KEY COGNITIVE RESULTS: backward digit span (working memory): +23% improvement (from 8.3 to 10.2 on the test; significant p<0.05); Raven's Progressive Matrices (fluid intelligence / abstract reasoning): +15% improvement (significant p<0.05); all five cognitive measures tested showed improvement with creatine vs placebo; the effect was not seen in the placebo arm (crossover validates that practice effects are controlled); MECHANISM: 31P-MRS (phosphorus magnetic resonance spectroscopy) studies in other work have confirmed that oral creatine supplementation increases brain phosphocreatine content by ~5–15%; during sustained cognitive work, brain ATP dips slightly before PCr can replenish it — higher PCr stores → faster ATP replenishment → less cognitive "dip" during sustained load; the effect is largest for tasks requiring sustained rapid ATP regeneration: working memory (constant active maintenance), executive function, dual-task performance, sleep deprivation resistance
Brain PCr and Aging
the longevity argument for creatine — multiple lines of evidence connect declining creatine metabolism with aging: BRAIN CREATINE DECLINE WITH AGE: Pfefferbaum A et al. (1999, NMR in Biomedicine): 31P-MRS in healthy adults across age groups; total creatine + phosphocreatine in frontal gray matter declined significantly with age (~10–15% lower in adults 60+ vs adults 20–30); this decline parallels cognitive slowing and processing speed reductions characteristic of normal aging; CREATINE KINASE ACTIVITY DECLINES WITH AGE: brain CK (the enzyme that uses PCr to regenerate ATP) activity decreases in aging human brain tissue; this compound effect (lower substrate PCr + lower enzyme activity) means aged neurons have reduced capacity to buffer ATP — neurons become more vulnerable to transient energy deficits during stress; CREATINE AND TBI/CONCUSSION: Sullivan PG et al. (2000): creatine supplementation in mice prior to TBI significantly reduced cortical damage (brain damage was ~36% smaller in creatine-supplemented mice); the mechanism: sustained brain energy demand after injury exceeds capacity — creatine provides a larger PCr reserve to buffer this demand; DEPRESSION AND CREATINE: Kondo DG et al. (2011): pilot RCT, adolescent females with major depressive disorder, creatine 4g/day + SSRI × 8 weeks: significantly greater HDRS reduction vs SSRI alone; brain phosphocreatine increased (31P-MRS confirmed); the energy deficiency hypothesis of depression: mitochondrial dysfunction in depressed patients reduces PCr; creatine supplementation restores brain energy buffer → augments antidepressant effects; CREATINE AND SLEEP DEPRIVATION: McMorris T et al. (2006): 24 hours sleep deprivation, creatine 0.03g/kg × 1 week: attenuated cognitive performance decrements; MELAS (mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes): a rare mitochondrial disorder; high-dose creatine (4g/day) is sometimes used as adjunctive treatment to support brain energy metabolism
Monohydrate Only
the forms comparison — the supplement industry has created ~15 forms of creatine, most with higher prices and claims of superiority over the original monohydrate; none has proven superior in well-designed trials: CREATINE MONOHYDRATE (CM): the original; extensively studied since the 1990s; 88% creatine by molecular weight (12% water); raises muscle and brain PCr reliably at 3–5g/day; highly cost-effective (~$15–25 for a 3-month supply); IWF, IOC, and NCAA permitted; the only form with large-scale RCT evidence for muscle, strength, and cognitive outcomes; CREATINE HCl (hydrochloride): higher water solubility (more soluble than CM); this is claimed to improve absorption → allow lower doses; problem: absorption of CM from the gut is already ~90–95%; better water solubility does not mean better intestinal absorption; a 2016 comparison study (Cooper R et al.) found no difference in muscle creatine accumulation between CM and HCl at equivalent doses; smaller dose (typically 750mg–1.5g sold vs 5g CM) likely delivers less creatine total; BUFFERED CREATINE (Kre-Alkalyn): claims to resist conversion to creatinine in the acidic stomach (creatine → creatinine is indeed a degradation pathway in acid); problem: gastric pH ≈ 2.0 would convert ~0.1% of creatine to creatinine in the 15–30 minutes gastric transit time — negligible; Jagim AR et al. (2012): head-to-head RCT, Kre-Alkalyn vs CM: no significant difference in muscle creatine content or performance; CREATINE ETHYL ESTER (CEE): rapid degradation to creatinine in the gut/bloodstream (worse than CM at raising muscle creatine); Jagim 2012 also included CEE — it was significantly INFERIOR to CM; BOTTOM LINE: spend the $0.15/day on creatine monohydrate; all other forms cost more and deliver equal or worse outcomes
Safety Profile
the most studied sports supplement with a near-impeccable safety record: KIDNEY CONCERNS (THE MOST COMMON WORRY): creatine is converted to creatinine and excreted renally; supplemental creatine increases serum creatinine slightly (as much as ~0.1–0.3 mg/dL); this is NOT kidney damage — it is the increased substrate being excreted; eGFR (calculated from creatinine using CKD-EPI formula) will show a slight decrease artifact — eGFR algorithms were not developed for creatine users; cystatin C (a renal biomarker not affected by muscle creatine content) remains normal in creatine users with healthy kidneys; Bender A et al. (2008): 5 years creatine use, 5 Parkinson disease patients: no adverse renal effects; Roberts MD et al. (multiple studies): long-term creatine use does not affect actual renal function; CAUTION: individuals with pre-existing CKD (chronic kidney disease, reduced eGFR) should avoid supplemental creatine or use only with physician monitoring — their kidneys are already stressed; HAIR LOSS CONCERN: van der Merwe J et al. (2009): 3-week creatine loading in college rugby players → serum DHT (dihydrotestosterone) increased +56% vs baseline; however: DHT returned to normal after loading phase; no hair was measured; the mechanism is unclear; studies examining serum testosterone (not DHT) with creatine supplementation show no consistent increase; the clinical relevance of a transient DHT increase for hair loss has not been validated; WEIGHT: creatine causes ~1–2 kg water retention in muscle intracellularly (creatine is osmotically active — draws water into muscle cells); this is intra-muscular water (beneficial for cell volume signaling), not subcutaneous puffiness; the water is lost within 1–2 weeks of stopping; LOADING PHASE (optional): 20g/day (4×5g) for 5–7 days → saturates muscle creatine stores in 1 week vs 3–4 weeks at 3–5g/day; produces more GI discomfort (mild); no superiority for long-term outcomes after 4 weeks — skip loading if GI-sensitive or just prioritizing brain effects
Ready to build the full protocol?
The Longevity Stack ranks 20+ compounds by evidence tier — the full biomarker panel, VO2 max protocol, sleep science, hormone chapter, and three budget-level stacks, built from the same research on this page.
Get the Longevity Stack → $19
Creatine Evidence by Target Outcome
| Outcome | Evidence Quality | Key Study/Meta-analysis | Effect Size |
|---|
| Muscle strength (resistance training) | ⭐⭐⭐⭐⭐ Very strong | Rawson & Venezia 2011 meta (N=400+) | +20% additional strength gain vs placebo over 4–12 weeks |
| Working memory (adults) | ⭐⭐⭐⭐ Strong | Rae 2003 (Proc Royal Soc B) | +23% backward digit span; +15% Raven's matrices |
| Cognitive performance under stress/sleep deprivation | ⭐⭐⭐ Moderate | McMorris 2006; Dworak 2017 | Attenuated decline during 24-hr sleep dep |
| Cognitive function in older adults | ⭐⭐⭐⭐ Strong | Watanabe 2002; Rawson 2008; Alves 2013 | +20–25% on processing speed; +10–15% memory tasks |
| Sarcopenia prevention in elderly | ⭐⭐⭐⭐ Strong | Devries & Phillips 2014 meta-analysis | +1.37 kg lean mass vs placebo; better with resistance training |
| Depression augmentation | ⭐⭐⭐ Moderate | Kondo 2011; Lyoo 2012 | Significant HDRS reduction as SSRI add-on; 31P-MRS confirmed PCr increase |
| Bone health | ⭐⭐ Emerging | Chilibeck 2015; Fairman 2019 | Modest benefit, possibly via increased IGF-1 and muscle tension on bone |
Creatine Protocol — Dosing, Timing, and Who Benefits Most
Daily maintenance (the recommended approach): 3–5g creatine monohydrate daily; no loading phase required for most users; loading (20g/day × 5–7 days) saturates stores faster but is optional; 3g/day: reaches the same plateau as 5g/day by 28 days; 5g/day: reaches plateau slightly faster; beyond 5g/day: minimal additional muscle saturation (excess is excreted as creatinine); brain creatine uptake is slower than muscle (requires months of consistent supplementation to peak); for neurological/cognitive benefits, allow at least 4–8 weeks before expecting maximal effect; timing: any time of day; timing relative to meals or exercise has no meaningful effect at steady-state; morning with breakfast is the most practical for adherence; with or without food; SPECIAL POPULATIONS WITH LARGEST EXPECTED BENEFIT: VEGETARIANS/VEGANS: near-zero dietary creatine → largest % increase from supplementation → Rae-magnitude cognitive effects most likely; start at 3g/day (vegetarian stores saturate at lower doses than meat-eaters); OLDER ADULTS (60+): declining endogenous synthesis + declining CK activity + declining muscle creatine stores → creatine supplementation addresses multiple aging-related deficits; 5g/day with resistance training is the most evidence-supported anti-sarcopenia protocol; COGNITIVE ATHLETES (academic, professional, high cognitive demand workers): the Rae 2003 effect is most relevant when baseline stores are partially depleted (vegetarians, high mental workload, aging); ATHLETES IN HIGH-INTENSITY SPORTS: the original evidence base; 3–5g/day is equivalent to loading for long-term use; CAUTION: individuals with pre-existing CKD should consult physician; individuals concerned about hair loss (family history of androgenic alopecia) may choose to cycle creatine or avoid loading phases to minimize transient DHT spikes (though causality is not established); FORMS: creatine monohydrate exclusively — other forms are more expensive and not superior.
Creatine Monohydrate →
Creatine Capsules →
More LongevityLab protocols
As an Amazon Associate, LongevityLab earns from qualifying purchases made through links on this page. This does not affect the price you pay.